NPs Basic Information

Name
Valylvaline anhydride
Molecular Formula C10H18N2O2
IUPAC Name*
3,6-di(propan-2-yl)piperazine-2,5-dione
SMILES
CC(C)C1C(=O)NC(C(=O)N1)C(C)C
InChI
InChI=1S/C10H18N2O2/c1-5(2)7-9(13)12-8(6(3)4)10(14)11-7/h5-8H,1-4H3,(H,11,14)(H,12,13)
InChIKey
QGMAWEIDGADSAC-UHFFFAOYSA-N
Synonyms
Valylvaline anhydride; 5625-44-5; 3,6-di(propan-2-yl)piperazine-2,5-dione; 3,6-Diisopropyl-2,5-piperazinedione; Cyclo(L-Val-L-Val); L-Valyl-valine anhydride; 2,5-Piperazinedione, 3,6-bis(1-methylethyl)-; SCHEMBL6439632; DTXSID00971680; 3,6-Diisopropylpiperazin-2,5-dione; 3,6-diisopropylpiperazine-2,5-dione; AKOS006281827; 3,6-diisopropylpipera-zine-2,5-dione; 3,6-Diisopropyl-2,5-piperazinedione #; (l,l)-cis-3,6-Diisopropylpiperazine-2,5-dione; 3,6-Di(propan-2-yl)-3,6-dihydropyrazine-2,5-diol; 2,5 Piperazinedione, 3,6-bis(1-methylethyl)-, (35)-trans-
CAS 5625-44-5
PubChem CID 519728
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic acids and derivat
      • Class: Carboxylic acids and deri
        • Subclass: Amino acids, peptides, an
          • Direct Parent: Alpha amino acids and der

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Loading...
Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Showing 0 to 0 of 0 entries

NPs Physi-Chem Properties

Molecular Weight: 198.26 ALogp: 1.4
HBD: 2 HBA: 2
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 58.2 Aromatic Rings: 1
Heavy Atoms: 14 QED Weighted: 0.685

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.856 MDCK Permeability: 0.00000673
Pgp-inhibitor: 0 Pgp-substrate: 0.37
Human Intestinal Absorption (HIA): 0.016 20% Bioavailability (F20%): 0.082
30% Bioavailability (F30%): 0.063

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.932 Plasma Protein Binding (PPB): 41.67%
Volume Distribution (VD): 0.786 Fu: 52.72%

ADMET: Metabolism

CYP1A2-inhibitor: 0.018 CYP1A2-substrate: 0.084
CYP2C19-inhibitor: 0.037 CYP2C19-substrate: 0.714
CYP2C9-inhibitor: 0.026 CYP2C9-substrate: 0.087
CYP2D6-inhibitor: 0.012 CYP2D6-substrate: 0.128
CYP3A4-inhibitor: 0.045 CYP3A4-substrate: 0.268

ADMET: Excretion

Clearance (CL): 4.907 Half-life (T1/2): 0.728

ADMET: Toxicity

hERG Blockers: 0.005 Human Hepatotoxicity (H-HT): 0.308
Drug-inuced Liver Injury (DILI): 0.24 AMES Toxicity: 0.04
Rat Oral Acute Toxicity: 0.155 Maximum Recommended Daily Dose: 0.017
Skin Sensitization: 0.039 Carcinogencity: 0.035
Eye Corrosion: 0.004 Eye Irritation: 0.018
Respiratory Toxicity: 0.092
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

*Note: the compound similarity was calculated by RDKIT.